Kosmos Energy Limited Director/PDMR Shareholding

RNS Number : 2357W

Kosmos Energy Limited

07 February 2025

 

Kosmos Energy Ltd (the "Company")
PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

06 February 2025

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Stock in the Company:

PDMR	Date of transaction	No. of shares vested	No. of shares granted	No. of shares sold or withheld
Christopher J. Ball	4 February 2025	0	0	138,584
Christopher J. Ball	5 February 2025	0	0	84,898
Josh R. Marion	4 February 2025	0	0	10,379
Josh R. Marion	5 February 2025	0	0	10,354
Ronald W. Glass	4 February 2025	0	0	10,379
Ronald W. Glass	5 February 2025	0	0	10,354
Andrew G. Inglis	4 February 2025	0	0	139,002
Andrew G. Inglis	5 February 2025	0	0	138,689
Neal D. Shah	4 February 2025	0	0	78,191
Neal D. Shah	5 February 2025	0	0	78,015

 

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

 

Josh R. Marion

Corporate Secretary

CONTACT:

Investor Relations

Jamie Buckland
[phone]
[e-mail]

Media Relations

Thomas Golembeski
[phone]
[e-mail]

 

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Christopher J. Ball
b)	Position / status	SVP and Chief Commercial Officer
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	138,584 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Company's Long Term Incentive Plan (the "Plan").
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
	Currency	USD
	Price	3.1149
	Volume	138,584
	Total	431,675.30
d)	Aggregated information
	Price	3.1149
	Volume	138,584
	Total	431,675.30
e)	Date of the transactions	4 February 2025
f)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	84,898 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
	Currency	USD
	Price	3.1219
	Volume	84,898
	Total	265,043.07
d)	Aggregated information
	Price	3.1219
	Volume	84,898
	Total	265,043.07
e)	Date of the transactions	5 February 2025
f)	Place of the transaction	NYSE

 

 

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Josh R. Marion
b)	Position / status	SVP and General Counsel
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	10,379 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
	Currency	USD
	Price	3.1149
	Volume	10,379
	Total	32,329.55
d)	Aggregated information
	Price	3.1149
	Volume	10,379
	Total	32,329.55
e)	Date of the transactions	4 February 2025
f)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	10,354 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
	Currency	USD
	Price	3.1219
	Volume	10,354
	Total	32,324.15
d)	Aggregated information
	Price	3.1219
	Volume	10,354
	Total	32,324.15
e)	Date of the transactions	5 February 2025
f)	Place of the transaction	NYSE

 

 

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Ronald W. Glass
b)	Position / status	Vice President and Chief Accounting Officer
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	10,379 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
	Currency	USD
	Price	3.1149
	Volume	10,379
	Total	32,329.55
d)	Aggregated information
	Price	3.1149
	Volume	10,379
	Total	32,329.55
e)	Date of the transactions	4 February 2025
f)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	10,354 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
	Currency	USD
	Price	3.1219
	Volume	10,354
	Total	32,324.15
d)	Aggregated information
	Price	3.1219
	Volume	10,354
	Total	32,324.15
e)	Date of the transactions	5 February 2025
f)	Place of the transaction	NYSE

 

 

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Andrew G. Inglis
b)	Position / status	Chairman and Chief Executive Officer
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	139,002 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
	Currency	USD
	Price	3.1149
	Volume	139,002
	Total	432,977.33
d)	Aggregated information
	Price	3.1149
	Volume	139,002
	Total	432,977.33
e)	Date of the transactions	4 February 2025
f)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	138,689 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
	Currency	USD
	Price	3.1219
	Volume	138,689
	Total	432,973.19
d)	Aggregated information
	Price	3.1219
	Volume	138,689
	Total	432,973.19
e)	Date of the transactions	5 February 2025
f)	Place of the transaction	NYSE

 

 

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Neal D. Shah
b)	Position / status	Senior Vice President and Chief Financial Officer
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	78,191 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
	Currency	USD
	Price	3.1149
	Volume	78,191
	Total	243,557.15
d)	Aggregated information
	Price	3.1149
	Volume	78,191
	Total	243,557.15
e)	Date of the transactions	4 February 2025
f)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	78,015 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
	Currency	USD
	Price	3.1219
	Volume	78,015
	Total	243,555.03
d)	Aggregated information
	Price	3.1219
	Volume	78,015
	Total	243,555.03
e)	Date of the transactions	5 February 2025
f)	Place of the transaction	NYSE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHSSLFIMEISEFE